Spring Meeting 2019


On 4th and 5th April, 2019 the fourth annual Leprosy Research Initiative (LRI) Spring Meeting was held in Veenendaal, the Netherlands with a total attendance of 75 participants from 21 countries among whom were representatives from the Turing Foundation (LRI’s co-funder), the Global Partnership for Zero Leprosy (GPZL), the European and Developing Countries Clinical Trial Partnership (EDCTP), Novartis Foundation and R2STOP.


As in previous years, the meeting was devoted to presentations on the progress and results of LRI funded projects, and representatives of all funded projects were invited to participate. In addition, for the second time representatives of projects funded by R2STOP participated in the meeting. Moreover, it serves as a meeting point where researchers can meet each other and can make new connections. In addition to the 33 progress presentations, the representative from the EDCTP presented the upcoming EDCTP funding opportunities.


The afternoon of the second day was devoted to the GPZL, starting with a plenary session with speakers addressing different aspects of the GPZL and LRI research agenda, followed by discussion groups on how they might collaborate across institutions, disciplines and countries. LRI and the GPZL are working together to outline next steps for this collaboration. For more information on potential research collaborations please contact Courtenay Dusenbury (This email address is being protected from spambots. You need JavaScript enabled to view it.) and Nienke Veldhuijzen (This email address is being protected from spambots. You need JavaScript enabled to view it.).


A meeting report about the Spring Meeting was submitted to Leprosy Review.



GPZL 2C Horizontal